Amr Mohamed, MD
Internal Medicine · Cleveland, OHNPI 1306281019
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $55,135 of the $72,275 with a category attached, or 76.3%. Ipsen Biopharmaceuticals, Inc accounts for 78.2% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2021 at $34,072 and has fallen 95.9% since, to $1,409 in 2025. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $701.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$56K
- Exelixis Inc.$9K
- Tersera Therapeutics LLC$3K
- Advanced Accelerator Applications$2K
- Novartis$1K
- Tempus AI, Inc$196
- plus $806 from 17 others
Across 3 payments — averaging $97,042 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$291K
What the payments were for
- Consulting fees$7,70811%
- Speaking & faculty fees$55,13576%
- Travel & lodging$7,02810%
- Food & beverage$2,3133%
- Education$900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 40 | $56,483 |
| Exelixis Inc. | 16 | $8,782 |
| Tersera Therapeutics LLC | 6 | $2,918 |
| Advanced Accelerator Applications | 1 | $1,880 |
| Novartis | 6 | $1,209 |
| Tempus AI, Inc | 2 | $196 |
| Boston Scientific | 1 | $120 |
| Eisai Inc. | 5 | $115 |
| Pfizer | 5 | $109 |
| Johnson & Johnson | 1 | $90 |
| AstraZeneca | 4 | $74 |
| Bayer | 3 | $62 |
| Merck | 3 | $50 |
| Impulse Dynamics (USA) Inc. | 1 | $32 |
| Edwards Lifesciences | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| GSK | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Beigene USA, Inc. | 1 | $16 |
| Taiho Oncology, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Puma Biotechnology, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOMATULINE DEPOT$42,744
- ONIVYDE$17,070
- Cabometyx$8,475
- Lutathera$2,980
- Xermelo$2,808
- WATCHMAN Access System$120
- XT CDX$100
How this compares
$72,275 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 27 | $2,455 |
| LoperamideLoperamide Hcl | 24 | $550 |
| Prochlorperazine Maleate | 28 | $296 |
| Oxycodone Hcl | 12 | $212 |
| Prednisone | 18 | $39 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Cleveland
- Cyrus HarrisCleveland$726K
- Marina MagreyCleveland$312K
- Joshua LonginowCleveland$241K
- Emad MansoorCleveland$219K
- Syed BukhariCleveland$165K
- Vadim KoshkinCleveland$159K
- Suresh Kumar BalasubramanianCleveland$148K
- Christine Tanaka-EspositoCleveland$123K
- Carla HarwellCleveland$75K
- Adriano TonelliCleveland$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.